Monday at the conference, PSA itself also got some attention, as researchers from Johns Hopkins University reported that by using the "prostate health index" – which combines measuring three different forms of PSA - they were able to predict which biopsies of men with early stage prostate cancer monitored by watchful waiting would show a clinical worsening...For additional coverage of AACR news, see AACR Roundup on pages 6 and 7
By Anette Breindl | Bio Perspectives | Tuesday, April 20, 2010
Image Cranky commentary by Cynthia Robbins-Roth To continue the spirit of Halloween, we start off our monthly roundup of BioWhirled fun with this important news flash from my favorite journal, The Funny Times...FBI agent Stephanie Douglas was pretty clear about what the evidence showed in court: "Mr. Harkonen lied to the public about the results of a clinical trial and offered false hope to people stricken with a deadly disease...This all started with clinical testing for a prenatal test for Down
continued to show improvements in the resolution of their signs and symptoms of treatment-failure gout with continuing pegloticase treatment, extending the positive clinical results seen in Phase III...The two clinical efficacy endpoints of most interest, gout flares and gout tophi, showed an increasing proportion of patients with favorable response over time...Incyte Corp., of Wilmington, Del., reported results from a 28-day Phase IIa trial showing that its orally available janus kinase (JAK
By Anette Breindl | Bio Perspectives | Tuesday, October 28, 2008
According to staff writer Amanda Pederson, "Based on this early analysis of the two Phase III clinical trials, Allergan says it hopes to file a supplemental biologics license application (sBLA) with the FDA to use Botox in chronic migraine by the middle of next year...25's Financing Roundup that "Tobacco the killer also could become tobacco the healer under a strange-yet-not-so-strange bedfellows type arrangement between Canadian vaccine maker Medicago Inc
By Amanda Lyle | Bio Perspectives | Tuesday, October 14, 2008
Monday at the conference, PSA itself also got some attention, as researchers from Johns Hopkins University reported that by using the "prostate health index" – which combines measuring three different forms of PSA - they were able to predict which biopsies of men with early stage prostate cancer monitored by watchful waiting would show a clinical worsening...For additional coverage of AACR news, see AACR Roundup on pages 6 and 7